MultiPlan Co. (NYSE:MPLN - Get Free Report)'s share price was up 6.7% on Thursday . The stock traded as high as $0.85 and last traded at $0.85. Approximately 136,238 shares traded hands during mid-day trading, a decline of 91% from the average daily volume of 1,511,401 shares. The stock had previously closed at $0.80.
MultiPlan Stock Up 3.1 %
The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 2.65. The firm's 50 day simple moving average is $0.98 and its two-hundred day simple moving average is $1.31. The firm has a market cap of $531.48 million, a price-to-earnings ratio of -5.50 and a beta of 0.60.
MultiPlan (NYSE:MPLN - Get Free Report) last issued its quarterly earnings data on Thursday, February 29th. The company reported ($0.06) earnings per share for the quarter. MultiPlan had a negative return on equity of 8.31% and a negative net margin of 9.54%. The business had revenue of $244.14 million during the quarter.
Hedge Funds Weigh In On MultiPlan
Several hedge funds have recently bought and sold shares of MPLN. Neo Ivy Capital Management bought a new stake in shares of MultiPlan during the 2nd quarter valued at approximately $28,000. Power Corp of Canada bought a new stake in shares of MultiPlan during the 1st quarter valued at approximately $33,000. Virtu Financial LLC bought a new stake in MultiPlan during the 2nd quarter worth approximately $70,000. Sei Investments Co. bought a new stake in MultiPlan during the 3rd quarter worth approximately $26,000. Finally, SG Americas Securities LLC bought a new stake in MultiPlan during the 3rd quarter worth approximately $27,000. 87.15% of the stock is owned by institutional investors.
About MultiPlan
(
Get Free Report)
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.
See Also
Before you consider MultiPlan, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MultiPlan wasn't on the list.
While MultiPlan currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
